Inka Scheffrahn

1.2k total citations
13 papers, 821 citations indexed

About

Inka Scheffrahn is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Inka Scheffrahn has authored 13 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in Inka Scheffrahn's work include Radiopharmaceutical Chemistry and Applications (6 papers), Peptidase Inhibition and Analysis (6 papers) and Cell Adhesion Molecules Research (6 papers). Inka Scheffrahn is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Peptidase Inhibition and Analysis (6 papers) and Cell Adhesion Molecules Research (6 papers). Inka Scheffrahn collaborates with scholars based in Germany, Sweden and Japan. Inka Scheffrahn's co-authors include Björn Öbrink, Bernhard B. Singer, Süleyman Ergün, Robert Kammerer, Dirk Schadendorf, Iris Helfrich, Sönke Bartling, Joachim Weis, Kristmundur Sigmundsson and Verena von Felbert and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Inka Scheffrahn

13 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inka Scheffrahn Germany 13 351 344 272 149 127 13 821
Maarten Balzar Netherlands 5 494 1.4× 481 1.4× 176 0.6× 206 1.4× 115 0.9× 7 1.0k
Kevin B. Leslie Canada 12 494 1.4× 236 0.7× 108 0.4× 335 2.2× 141 1.1× 16 919
Isabelle Ronsse Belgium 18 289 0.8× 507 1.5× 71 0.3× 564 3.8× 163 1.3× 28 1.1k
Sonja Offner Germany 8 496 1.4× 641 1.9× 329 1.2× 309 2.1× 181 1.4× 8 1.1k
Kathy Mulgrew United States 11 412 1.2× 557 1.6× 263 1.0× 280 1.9× 40 0.3× 24 980
Paola Porcedda Italy 12 419 1.2× 250 0.7× 151 0.6× 302 2.0× 108 0.9× 17 800
Francesca Zammarchi United Kingdom 13 344 1.0× 534 1.6× 192 0.7× 161 1.1× 51 0.4× 47 875
A. Miyajima Japan 14 348 1.0× 223 0.6× 100 0.4× 452 3.0× 76 0.6× 27 992
Fiorella Petronzelli Italy 18 480 1.4× 252 0.7× 200 0.7× 391 2.6× 103 0.8× 41 1.2k
C Morimoto United States 12 249 0.7× 289 0.8× 142 0.5× 489 3.3× 81 0.6× 16 930

Countries citing papers authored by Inka Scheffrahn

Since Specialization
Citations

This map shows the geographic impact of Inka Scheffrahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inka Scheffrahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inka Scheffrahn more than expected).

Fields of papers citing papers by Inka Scheffrahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inka Scheffrahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inka Scheffrahn. The network helps show where Inka Scheffrahn may publish in the future.

Co-authorship network of co-authors of Inka Scheffrahn

This figure shows the co-authorship network connecting the top 25 collaborators of Inka Scheffrahn. A scholar is included among the top collaborators of Inka Scheffrahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inka Scheffrahn. Inka Scheffrahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ullrich, Nico, Anja Heinemann, Inka Scheffrahn, et al.. (2015). CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival. Cancer Research. 75(9). 1897–1907. 23 indexed citations
2.
3.
Helfrich, Iris, Inka Scheffrahn, Sönke Bartling, et al.. (2013). Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma. The Journal of Experimental Medicine. 210(4). 853–853. 94 indexed citations
4.
Singer, Bernhard B., Inka Scheffrahn, Robert Kammerer, et al.. (2010). Deregulation of the CEACAM Expression Pattern Causes Undifferentiated Cell Growth in Human Lung Adenocarcinoma Cells. PLoS ONE. 5(1). e8747–e8747. 74 indexed citations
5.
Helfrich, Iris, Inka Scheffrahn, Sönke Bartling, et al.. (2010). Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma. The Journal of Experimental Medicine. 207(3). 491–503. 148 indexed citations
6.
Singer, Bernhard B., Esther Klaile, Inka Scheffrahn, et al.. (2005). CEACAM1 (CD66a) mediates delay of spontaneous and Fas ligand-induced apoptosis in granulocytes. European Journal of Immunology. 35(6). 1949–1959. 71 indexed citations
7.
Scheffrahn, Inka, Bernhard B. Singer, Kristmundur Sigmundsson, Lothar Lucka, & Björn Öbrink. (2005). Control of density-dependent, cell state-specific signal transduction by the cell adhesion molecule CEACAM1, and its influence on cell cycle regulation. Experimental Cell Research. 307(2). 427–435. 28 indexed citations
8.
9.
Öbrink, Björn, Hiroki Sawa, Inka Scheffrahn, et al.. (2002). Computational Analysis of Isoform‐Specific Signal Regulation by CEACAM1—A Cell Adhesion Molecule Expressed in PC12 Cells. Annals of the New York Academy of Sciences. 971(1). 597–607. 24 indexed citations
10.
Hübinger, Gabriele, Elke Müller, Inka Scheffrahn, et al.. (2001). CD30-mediated cell cycle arrest associated with induced expression of p21CIP1/WAF1 in the anaplastic large cell lymphoma cell line Karpas 299. Oncogene. 20(5). 590–598. 55 indexed citations
11.
Scheffrahn, Inka, et al.. (2000). The tumor growth-inhibiting cell adhesion molecule CEACAM1 (C-CAM) is differently expressed in proliferating and quiescent epithelial cells and regulates cell proliferation.. PubMed. 60(5). 1236–44. 101 indexed citations
12.
Hübinger, Gabriele, Inka Scheffrahn, Elke Müller, et al.. (1999). The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation. Experimental Hematology. 27(12). 1796–1805. 32 indexed citations
13.
Gruss, H J, et al.. (1996). The CD30 ligand and CD40 ligand regulate CD54 surface expression and release of its soluble form by cultured Hodgkin and Reed-Sternberg cells.. PubMed. 10(5). 829–35. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maarten Balzar Breakdown of academic impact, for papers by Kevin B. Leslie Breakdown of academic impact, for papers by Isabelle Ronsse Breakdown of academic impact, for papers by Sonja Offner Breakdown of academic impact, for papers by Kathy Mulgrew Breakdown of academic impact, for papers by Paola Porcedda Breakdown of academic impact, for papers by Francesca Zammarchi Breakdown of academic impact, for papers by A. Miyajima Breakdown of academic impact, for papers by Fiorella Petronzelli Breakdown of academic impact, for papers by C Morimoto
Rankless by CCL
2026